Fibroblast growth factor receptor 1
Also known as: BFGFR, CEK, FGFBR, FGFR1, FLG, FLT2, HBGFR
Function
Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.
Classification
- Family (Pfam)
- PF07679 I-set, PF00047 ig, PF07714 PK_Tyr_Ser-Thr
- InterPro
- FGF_rcpt_1, FGF_rcpt_fam, Ig-like_dom, Ig-like_dom_sf, Ig-like_fold, Ig_I-set, Ig_sub, Ig_sub2, Immunoglobulin_dom, Kinase-like_dom_sf, Prot_kinase_dom, Protein_kinase_ATP_BS, RTK, Ser-Thr/Tyr_kinase_cat_dom, Tyr_kinase_AS, Tyr_kinase_cat_dom
- Functional cluster
- Immunoglobulin-Domain Cell Adhesion Proteins
Experimental structures · PDB · 81
- 1AGW X-ray 2.40A
- 1CVS X-ray 2.80A
- 1EVT X-ray 2.80A
- 1FGI X-ray 2.50A
- 1FGK X-ray 2.00A
- 1FQ9 X-ray 3.00A
- 1XR0 NMR
- 2CR3 NMR
- 2FGI X-ray 2.50A
- 3C4F X-ray 2.07A
- 3DPK X-ray 1.95A
- 3GQI X-ray 2.50A
- … and 69 more
A predicted model is available from AlphaFold.
Gene Ontology · 52
- GO:0031410 cytoplasmic vesicle
- GO:0005829 cytosol
- GO:0005576 extracellular region
- GO:0098978 glutamatergic synapse
- GO:0016020 membrane
- GO:0005634 nucleus
- GO:0005886 plasma membrane
- GO:0098794 postsynapse
- GO:0043235 receptor complex
- GO:0005524 ATP binding
- GO:0017134 fibroblast growth factor binding
- GO:0005007 fibroblast growth factor receptor activity
- GO:0008201 heparin binding
- GO:0042802 identical protein binding
- GO:0042803 protein homodimerization activity
- GO:0004713 protein tyrosine kinase activity
- GO:0090722 receptor-receptor interaction
- GO:0042169 SH2 domain binding
- GO:0055074 calcium ion homeostasis
- GO:0016477 cell migration
- GO:0044344 cellular response to fibroblast growth factor stimulus
- GO:0071529 cementum mineralization
- GO:0043009 chordate embryonic development
- GO:0071344 diphosphate metabolic process
- GO:0006351 DNA-templated transcription
- GO:0001837 epithelial to mesenchymal transition
- GO:0008543 fibroblast growth factor receptor signaling pathway
- GO:0035607 fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development
- GO:0000165 MAPK cascade
- GO:0000122 negative regulation of transcription by RNA polymerase II
- GO:0001764 neuron migration
- GO:0018108 peptidyl-tyrosine phosphorylation
- GO:0048015 phosphatidylinositol-mediated signaling
- GO:0043536 positive regulation of blood vessel endothelial cell migration
- GO:0045787 positive regulation of cell cycle
- GO:0045597 positive regulation of cell differentiation
- GO:0008284 positive regulation of cell population proliferation
- GO:2001028 positive regulation of endothelial cell chemotaxis
- GO:0043406 positive regulation of MAP kinase activity
- GO:0043410 positive regulation of MAPK cascade
- GO:0045666 positive regulation of neuron differentiation
- GO:0051897 positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- GO:0010518 positive regulation of phospholipase activity
- GO:1905564 positive regulation of vascular endothelial cell proliferation
- GO:0046777 protein autophosphorylation
- GO:0006468 protein phosphorylation
- GO:0045595 regulation of cell differentiation
- GO:0099151 regulation of postsynaptic density assembly
- GO:1904383 response to sodium phosphate
- GO:0001501 skeletal system development
- GO:0048705 skeletal system morphogenesis
- GO:0021847 ventricular zone neuroblast division
Disease associations
- Pfeiffer syndrome MONDO:0007043
- Jackson-Weiss syndrome MONDO:0007400
- hypogonadotropic hypogonadism 2 with or without anosmia MONDO:0007844
- osteoglophonic dysplasia MONDO:0008150
- trigonocephaly 1 MONDO:0008603
- encephalocraniocutaneous lipomatosis MONDO:0013074
- Hartsfield-Bixler-Demyer syndrome MONDO:0014196
Drugs targeting this protein · 24
- PAZOPANIB HYDROCHLORIDE inhibitor
- INFIGRATINIB PHOSPHATE inhibitor
- INFIGRATINIB inhibitor
- REGORAFENIB inhibitor
- RG-1530 inhibitor
- LUCITANIB inhibitor
- BRIVANIB ALANINATE inhibitor
- ORANTINIB inhibitor
- NINTEDANIB ESYLATE inhibitor
- FEXAGRATINIB inhibitor
- PD-0166285 HYDROCHLORIDE inhibitor
- ERDAFITINIB inhibitor
- E-7090 inhibitor
- FUTIBATINIB inhibitor
- BRIVANIB inhibitor
- LY-2874455 inhibitor
- FGFR INHIBITOR DEBIO 1347 inhibitor
- ROGARATINIB inhibitor
- TG100-801 inhibitor
- DERAZANTINIB inhibitor
- SURUFATINIB inhibitor
- PEMIGATINIB inhibitor
- ENMD-981693 inhibitor
- XL-999 inhibitor
Neighborhood · nearest proteins
Related proteins · sequence + function similarity
- Fibroblast growth factor receptor 1 1.00
- Fibroblast growth factor receptor 1 1.00
- Fibroblast growth factor receptor 1 0.98
- Fibroblast growth factor receptor 1 0.97
- Fibroblast growth factor receptor 3 0.97
- Fibroblast growth factor receptor 1-A 0.97
- Fibroblast growth factor receptor 1 0.97
- Fibroblast growth factor receptor 3 0.97
- Fibroblast growth factor receptor 3 0.96
- Fibroblast growth factor receptor 4 0.96
- Fibroblast growth factor receptor 4 0.95
- Fibroblast growth factor receptor 2 0.95
Co-cited proteins · studied together in the literature
- FGFR1 oncogene partner 2 3 shared papers
- Anosmin-1 6 shared papers
- Fibroblast growth factor 1 8 shared papers
- Fibroblast growth factor receptor 2 9 shared papers
- Zinc finger MYM-type protein 2 1 shared papers
- Fibroblast growth factor receptor 4 7 shared papers
- Centriolin 1 shared papers
- Centrosomal protein 43 1 shared papers
- Heparan-sulfate 6-O-sulfotransferase 1 2 shared papers
- NMDA receptor synaptonuclear signaling and neuronal migration factor 2 shared papers
- 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 3 shared papers
- Fibroblast growth factor receptor 1 1 shared papers
Literature · 84 cited papers
- DISP1 deficiency: Monoallelic and biallelic variants cause a spectrum of midline craniofacial malformations. Genet. Med. · 2024
- Mosaic activating mutations in FGFR1 cause encephalocraniocutaneous lipomatosis. Am. J. Hum. Genet. · 2016
- Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform. Fertil. Steril. · 2015
- The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients. J. Clin. Endocrinol. Metab. · 2014
- Novel de novo heterozygous FGFR1 mutation in two siblings with Hartsfield syndrome: A case of gonadal mosaicism. Am. J. Med. Genet. A · 2014
- FGFR1 mutations cause Hartsfield syndrome, the unique association of holoprosencephaly and ectrodactyly. J. Med. Genet. · 2013
- Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. Am. J. Hum. Genet. · 2013
- A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm. Leukemia · 2013
- SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome. PLoS Genet. · 2012
- Nedd4-1 binds and ubiquitylates activated FGFR1 to control its endocytosis and function. EMBO J. · 2011
- Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism. Proc. Natl. Acad. Sci. U.S.A. · 2011
- A novel mode of protein kinase inhibition exploiting hydrophobic motifs of autoinhibited kinases: discovery of ATP-independent inhibitors of fibroblast growth factor receptor. J. Biol. Chem. · 2011
- … and 72 more in the literature graph